We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Authors
Srour, Samer A.; Lee, Hun J.; Nomie, Krystle; Ye, Haige; Chen, Wendy; Oriabure, Onyeka; Romaguera, Jorge; Wang, Michael L.
- Abstract
The article focuses on findings of a study on a novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma. It states that the prognosis of patients who relapse after ibrutinib-based therapy is very poor, with reported low response rates, and mentions that combination of rituximab, lenalidomide and bortezomib was found to be tolerable with promising efficacy in a small phase I-II study.
- Subjects
MANTLE cell lymphoma; CANCER chemotherapy; RITUXIMAB; BORTEZOMIB; CLINICAL trials; THERAPEUTICS
- Publication
British Journal of Haematology, 2018, Vol 181, Issue 4, p561
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.14669